Lupin, Pred Forte
Lupin launches first generic version of Pred Forte in U.S., shares in green
Lupin Limited launches generic Pred Forte in the U.S., securing 180-day exclusivity, strengthening ophthalmic portfolio.
Lupin launches first generic of Pred Forte in US with 180-day exclusivity
Prednisolone Acetate Ophthalmic Suspension USP, 1% is a generic equivalent of Pred Forte Ophthalmic Suspension, 1% of AbbVie, Inc. and is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
Lupin Launches Generic Eye Treatment in US | 180-Day Exclusivity
Lupin has launched a generic ophthalmic solution in the US, Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1 per cent, with 180-day exclusivity. The drug is indicated for treating steroid-responsive inflammation of the eye.
Lupin launches first generic of $200 mn eye drop Pred Forte in USA with 180-Day exclusivity
Lupin Ltd has launched the first generic version of Pred Forte Ophthalmic Suspension USP, 1% in the US, targeting steroid-responsive eye inflammation. The company is entitled to 180 days of market exclusivity.
Lupin launches first generic formulation of Abbie’s drug to treat eye disorder
Global pharma major Lupin Limited on Tuesday announced the launch of the first generic version of Pred Forte (Prednisolone Acetate) Ophthalmic Suspension USP, 1% in the United States. According to the company’s press statement,
Lupin launches generic version of corticosteroid Prednisolone in United States
Lupin has announced the launch of the first generic version of Prednisolone Acetate Ophthalmic Suspension in the United States.
cnbctv185d
Explained: Why Lupin, Cipla and other Pharma stocks fell on Thursday
A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.
Lupin share down 3% as USFDA issues 5 observations for Biotech unit in Pune
Lupin share price slipped in trade after the company announced that United States Food and Drug Administration (USFDA) has ...
Pharmabiz2d
Lupin launches Aptivate Achi Bhookh Fest in Mumbai and suburbs
Lupin launches Aptivate Achi Bhookh Fest in Mumbai and suburbs: Our Bureau, Mumbai Monday, October 14, 2024, 15:30 Hrs [IST] LupinLife, the consumer healthcare division of global ...
Generic medicines a boon for poor and middle classes
Usage of generic medicines has been increased as they became boon to the poor and middle-class people because they are ...
money.rediff11d
Lupin Subsidiary Acquires 9 Brands in South Africa
Lupin's subsidiary, Pharma Dynamics, acquires 9 brands from MNI in South Africa, expanding its footprint in complementary and ...
The Financial Express12d
Lupin acquires nine brands of Medical Nutritional Institute in South Africa
This acquisition will enable Lupin gain access to MNI’s wide portfolio of nine brands, that are marketed as branded products in the South African retail sector, the company stated.
Lupin arm buys nine brands in South Africa
Lupin Ltd.'s South African subsidiary acquires nine brands from MNI, expanding its portfolio in the healthcare sector.
Stocks to buy in October: Lupin, Federal Bank, Prestige Estates, among Axis Securities’ top mid-cap, small-cap picks
Axis Securities has recommended seven midcap and smallcap stocks to buy in October and expects an upside potential of up to ...
Aytu BioScience: Strategic Commercialization with Lupin Pharma to Bolster ADHD Franchise Growth
Maxim Group analyst Naz Rahman reiterated a Buy rating on Aytu BioScience (AYTU – Research Report) yesterday and set a price target of ...